Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin
Publication Year
2001
Type
Journal Article
Abstract
Small molecules that affect specific protein functions can be valuable tools for dissecting complex cellular processes. Peptidoglycan synthesis and degradation is a process in bacteria that involves multiple enzymes under strict temporal and spatial regulation. We used a set of small molecules that inhibit the transglycosylation step of peptidoglycan synthesis to discover genes that help to regulate this process. We identified a gene responsible for the susceptibility of Escherichia coli cells to killing by glycolipid derivatives of vancomycin, thus establishing a genetic basis for activity differences between these compounds and vancomycin.
Keywords
Bacterial Proteins,
Mutation,
Escherichia coli,
Genes, Bacterial,
Anti-Bacterial Agents,
Microbial Sensitivity Tests,
Genetic Complementation Test,
Phenotype,
Oligosaccharides,
Lipoproteins,
Enzyme Inhibitors,
Glycosylation,
Peptidoglycan,
Vancomycin,
Drug Resistance, Microbial,
Vancomycin Resistance,
Drug Resistance, Multiple,
Hexosyltransferases,
N-Acetylmuramoyl-L-alanine Amidase,
Peptidoglycan Glycosyltransferase
Journal
Science
Volume
294
Issue
5541
Pages
361-4
Date Published
10/2001
ISSN Number
0036-8075
Alternate Journal
Science
PMID
11520949